Supporting consumers along their GLP-1 journey As the GLP-1 market segment grows, so will the demand for foods that support users across the various stages of their weight loss journey
Patience and consistency prove essential
This creates a healthy post-meal glucose response, satiety, muscle maintenance, and healthy body composition
Key Takeaways Wegovy pill and injection are both FDA-approved for weight management, but they differ in dosing schedules, absorption, and instructions
Careful dose escalation is fundamental to minimizing adverse events and ensuring patients can continue therapy long enough to see benefits
The obesity epidemic continues to affect millions of Americans, with approximately two-thirds of the population classified as overweight or obese.[1] Individuals who are overweight or have obesity are more likely to develop type 2 diabetes (T2D), though not everyone with excess weight develops the condition.[2] For non-diabetics seeking support with weight loss, semaglutide has gained significant attention